Evolution Summit Fall 2017

Register your interest

Please fill out the form below

Choose the option*

While we hope you can join us for this event, Marcus Evans delivers over 1000 annual events globally, so if we miss you this time we would love to keep you informed by email of other related events in your specific area of interest. Is that ok?

Yes    No

*Mandatory fields

  • Get a new challenge

  • A Common Quality Language for Better Biomedical Research Results


    Ulo Palm, a speaker at the marcus evans Evolution Summit 2012, on the necessity of common quality standards in unregulated biomedical research.

    Interview with: Ulo Palm, Senior Vice President - Clinical Operations & Biometrics, Forest Research Institute


    The lack of a common language on the quality of non-regulated biomedical research is resulting in the poor reproducibility of findings, says Ulo Palm, Senior Vice President - Clinical Operations & Biometrics, Forest Research Institute. This is wasting valuable resources and hindering innovation, as the majority of the work is having to be repeated by different laboratories, he adds.

    A speaker at the upcoming marcus evans Evolution Summit 2012, in Wheeling, Illinois, April 30 - May 2, Palm discusses how common standards for non-regulated biomedical research would create synergies that could lead to drug development breakthroughs.

    From your perspective, why is there poor reproducibility of biomedical research findings?

    There are no common quality standards or methods, therefore laboratories are producing different results that others are then unsuccessfully trying to validate. The majority of the efforts put into biomedical research are going into replicating work, instead of building on each other’s work and creating synergies. If you take into account that USD 100 billion a year is spent on mostly non-reproducible biomedical research, this has major implications from a productivity perspective.

    Besides not spending our money efficiently, we seem to be unable to turn the promises of modern biology into new effective drugs for patients worldwide.

    What should these standards include? How would compliance be monitored?

    They must cover the process from the concept of an idea to the publishing of research results. This is about creating a common language in biomedical research.

    These standards should be voluntary; we still have to continue to trust people. Scientists would state whether they followed the standards and over time, there would be methods developed to verify that they did. To start with, if labs were requested to provide a statement that they did follow the standards, it would go a long way.

    Would such standards nurture or hinder innovation and creativity?

    They would increase creativity significantly. There is a misconception of what creativity is. People often think that in order to be creative, there should not be any rules, but if you want to be productive with your creativity, you need to use tools in the way they were designed for.

    For example, you cannot be a very creative musician without knowing how to play any instruments. Only when you know and follow the basic rules can your mind free up for creativity. You do not want to be creative in how you conduct your research, but in the concept of research. If the technical aspects of biomedical research were standardized, scientists would really be able to focus on the science.

    We need a common quality language to create synergies in biomedical research that could lead to breakthroughs for patients who are desperately waiting for new research outcomes.

    Contact: Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits Division

    Tel: + 357 22 849 313
    Email: press@marcusevanscy.com

    About the Evolution Summit 2012

    This unique forum will take place at the Westin Chicago North Shore, Wheeling, Illinois, April 30 - May 2, 2012. Offering much more than any conference, exhibition or trade show, this exclusive meeting will bring together esteemed industry thought leaders and solution providers to a highly focused and interactive networking event. The Summit includes presentations on the future of drug development, developing a culture of safety and maximizing return on investment.

    For more information please send an email to info@marcusevanscy.com or visit the event website

    marcus evans group – life sciences / pharma sector portal

    The Pharma Network – marcus evans Summits group delivers peer-to-peer information on strategic matters, professional trends and breakthrough innovations.


    Please note that the Summit is a closed business event and the number of participants strictly limited.

    About marcus evans Summits

    marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to individually tailor their schedules of keynote presentations, think tanks, seminars and one-on-one business meetings. For more information, please visit www.marcusevans.com 

    All rights reserved. The above content may be republished or reproduced. Kindly inform us by sending an email to press@marcusevanscy.com